🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare brolucizumab (RTH258) ophthalmic so...
Status
Completed
Location
Contact Alcon Call Center for Trial Locations
Start Date
2014-12-08
Trial ID
NCT02307682
Treatments Being Tested
The purpose of this study is to generate additional safety and effectivenes...
Status
Completed
Location
Novartis Investigative Site
Start Date
2024-12-11
Trial ID
NCT05959304
Treatments Being Tested
The currently widely established and preferred protocol for the treatment o...
Status
Active Not Recruiting
Location
Berner Augenklinik
Start Date
2022-05-09
Trial ID
NCT04932980
Treatments Being Tested
The purpose of this study is to assess whether switching nAMD patients from...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-05-31
Trial ID
NCT04697953
Treatments Being Tested
This retrospective study included nAMD patients whose eyes were grouped int...
Status
Completed
Location
Novartis
Start Date
2021-12-01
Trial ID
NCT06178770
The purpose of this study was to evaluate the efficacy and safety of broluc...
Status
Completed
Location
Retina Associates SW
Start Date
2020-11-19
Trial ID
NCT04278417
Treatments Being Tested
The study is a prospective and retrospective, observational, single-arm, no...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2022-04-13
Trial ID
NCT05266495
Treatments Being Tested
This was a 64-week randomized, double-masked, multi-center, active-controll...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-09-25
Trial ID
NCT04005352
Treatments Being Tested
This was the cross-sectional study to assess the period prevalence of IOI i...
Status
Completed
Location
Novartis Investigative Site
Start Date
2020-07-15
Trial ID
NCT05146687
Treatments Being Tested
RAZORBILL was an observational, multicenter, multinational, open-label, stu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-02-23
Trial ID
NCT04662944
Treatments Being Tested